Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Honasa Consumer Limited is a digital‑first beauty and personal care house‑of‑brands — led by Mamaearth and a portfolio including THE derma CO, BBLUNT, Aqualogica, DR. SHETH'S, STAZE and newer acquisitions — selling skin, hair, baby care and color cosmetics through omnichannel distribution and owned service platforms like Momspresso and BBlunt Salons.
Q3 FY26 was a milestone quarter: reported revenue INR 602 crore (LFL INR 630 crore), 21%+ YoY growth, highest ever quarterly revenue, UVG of ~30%, EBITDA INR 66 crore (10.9% on reported basis) and PAT roughly doubled year‑on‑year, reflecting simultaneous top‑line scale and operating leverage.
Honasa converted channel momentum into offline reach with direct distribution expansion to ~2.7 lakh outlets and direct distributors billing 1.13 lakh outlets, while maintaining a negative working capital cycle (around -9 days) and improving EBITDA margins through marketing effectiveness and Opex leverage.
There was an accounting/settlement change with Flipkart that reduced reported revenue by ~INR 28 crore but did not affect contribution margin or absolute profitability; management emphasizes like‑for‑like growth and that core fundamentals, product innovation and category focus drove market share gains.
Strategically, management is prioritizing focus categories (75% of sales now in focus categories), product re‑innovation (multiple blind test wins), and targeted brand investments; they also set a financial goal of ~100 bps annual EBITDA margin improvement as they scale.
Personal Products
Personal Care
13,577 Cr
Low Risk
67.9
43.5
3.1
9.6
437.90
248.55
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stockHonasa Consumer Ltd (HONASA) is currently trading at 415.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Honasa Consumer Limited is a digital‑first beauty and personal care house‑of‑brands — led by Mamaearth and a portfolio including THE derma CO, BBLUNT, Aqualogica, DR. SHETH'S, STAZE and newer acquisitions — selling skin, hair, baby care and color cosmetics through omnichannel distribution and owned service platforms like Momspresso and BBlunt Salons. Q3 FY26 was a milestone quarter: reported revenue INR 602 crore (LFL INR 630 crore), 21%+ YoY growth, highest ever quarterly revenue, UVG of ~30%, EBITDA INR 66 crore (10.9% on reported basis) and PAT roughly doubled year‑on‑year, reflecting simultaneous top‑line scale and operating leverage. Honasa converted channel momentum into offline reach with direct distribution expansion to ~2.7 lakh outlets and direct distributors billing 1.13 lakh outlets, while maintaining a negative working capital cycle (around -9 days) and improving EBITDA margins through marketing effectiveness and Opex leverage. There was an accounting/settlement change with Flipkart that reduced reported revenue by ~INR 28 crore but did not affect contribution margin or absolute profitability; management emphasizes like‑for‑like growth and that core fundamentals, product innovation and category focus drove market share gains. Strategically, management is prioritizing focus categories (75% of sales now in focus categories), product re‑innovation (multiple blind test wins), and targeted brand investments; they also set a financial goal of ~100 bps annual EBITDA margin improvement as they scale.
Over the past 52 weeks, Honasa Consumer Ltd has traded between a low of ₹248.55 and a high of ₹437.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Honasa Consumer Ltd has a market capitalization of approximately 13,577.28. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Honasa Consumer Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 67.90 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 13,577.28 Cr, Honasa Consumer Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Honasa Consumer Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Honasa Consumer Ltd is 67.90. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Honasa Consumer said it is targeting ₹5,000-₹5,500 crore in revenue over the next five years as part of its FY31 vision.
ICICI Securities reiterated a BUY on Honasa Consumer and raised its target price to ₹550 from ₹500, implying nearly 32% upside from the ₹417 price referenced in the note.
The article says brokerages see up to 38% upside potential, with targets cited as high as ₹565.
The stock rose after Honasa reported a 177% YoY jump in Q4FY26 consolidated net profit to ₹69 crore from ₹25 crore.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Bearish
3
Neutral
7
Bullish
4
Bearish
8
Neutral
7
Bullish
31
Bearish
5
Neutral
0
Bullish
27
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
7781.15 | 25,395 Cr | 38.81 | 26.83 | 0.77 | 69.13 | 94.29 | 34.96 | ||
179.55 | 24,143 Cr | 223.07 | 53.56 | 0.00 | 24.01 | 28.64 | 19.56 | ||
404.00 | 17,641 Cr | 22.75 | 6.03 | 1.48 | 26.51 | 27.65 | 20.21 | ||
415.60 | 13,577 Cr | 67.90 | 9.61 | 0.72 | 14.16 | 17.48 | 9.57 | ||
589.25 | 7,697 Cr | 40.47 | 10.19 | 0.00 | 25.19 | 30.23 | 20.12 | ||
1233.15 | 2,230 Cr | 70.14 | 17.26 | 0.00 | 25.88 | 30.97 | 18.56 | ||
182.65 | 274 Cr | 85.39 | 11.77 | 0.27 | 13.72 | 18.56 | 13.61 | ||
| Median: 7 Co. | — | 415.60 | 13,577 Cr | 67.90 | 11.77 | 0.27 | 25.19 | 28.64 | 19.56 |
Merger/Acquisition
Honasa Consumer Ltd announced acquisition of a 58% majority stake in Fluence Pharma and will create subsidiary Honasa Health to scale nutraceuticals; Fluence reported ~INR 40 Crore revenue and 20%+ EBITDA margin in FY26.
Merger/Acquisition
On 23 June 2026 Honasa Consumer Limited announced acquisition of a 58% stake in Fluence Pharma and will form Honasa Health Private Limited to scale nutraceuticals; Fluence reported ~INR 40 Crore revenue and 20%+ EBITDA margin in FY26.
Merger/Acquisition
Honasa Consumer Limited's board approved acquiring 58% of Fluence Pharma Private Limited at ~ ₹ 135 Crores enterprise value (subject to closing adjustments) with the remaining 42% to be bought in two tranches over the next 5-7 years, and approved incorporation of wholly owned subsidiary Honasa Health Private Limited.
Merger/Acquisition
On June 23, 2026 Honasa Consumer Ltd's board approved acquisition of 58% of Fluence Pharma Pvt Ltd at ~ ₹135 Crores enterprise value (subject to closing adjustments) and to acquire remaining 42% in two tranches over 5-7 years; also approved incorporation of wholly owned Honasa Health Private Limited.
